J&J raises FY26 outlook following positive Q2
Johnson and Johnson (J&J) has achieved Q2 revenues totalling around $25.3bn, representing a year-over-year (YoY) uptick of 6.6%, with the …
-
-
Women’s health attracted record equity in 2025 as companies share capital
Women’s health companies secured a record $1.55bn in funding in 2025, hinting that investors' faith is growing in this sector. According …
-
THINK Surgical nets up to $65m with Symbiotic Capital debt facility
THINK Surgical has secured up to $65m in growth capital after entering into a debt facility arrangement with Symbiotic Capital, …
-
Newronika’s aDBS system secures CE mark with cloud data integration
Italian medtech company Newronika has secured the CE mark for the latest commercial version of αDBS, its adaptive deep brain …
-
Neuraptive secures exclusive licence from Washington University for nerve device
Neuraptive Therapeutics has secured an exclusive licence from Washington University in St Louis for a bioresorbable wireless electronic stimulation device …
-
Edwards Lifesciences served $10m penalty over JC Medical acquisition violations
Edwards Lifesciences has been hit with a $10m penalty to settle a court ruling that determined the company violated antitrust …
-
AAIC26: Cognito sheds light on biological underpinnings of Alzheimer’s headset
New data from Cognito Therapeutics has indicated that its Spectris device increases cerebrospinal fluid (CSF) HDL-like lipid transport particles, suggesting …
-
Health Canada authorises Dexcom G7 15 Day CGM
Health Canada has granted authorisation for the Dexcom G7 15 Day continuous glucose monitor (CGM) for adults aged 18 years …
-
Claria Medical secures FDA De Novo classification for hysterectomy device
Claria Medical has secured De Novo classification and marketing authorisation from the US Food and Drug Administration (FDA) for its …
-
Is your quality system built for 2026’s new regulatory reality?
The life sciences industry has always operated under pressure to stay ahead of regulatory change. But 2026 has raised the …
-
HistoSonics’ Edison histotripsy system obtains CE mark
HistoSonics has secured a European CE mark for its histotripsy system Edison, setting the stage for the device’s commercialisation across …
-
FDA clears Zeta Surgical’s robotic TMS navigation system
Zeta Surgical’s transcranial magnetic stimulation (TMS) robotic navigation system, designed to make delivering the treatment modality in treatment-resistant depression (TRD) …
-
En Carta secures $6.18m to expand molecular testing solutions
French deep-tech company En Carta Diagnostics has announced the first closing of €5m ($6.18m) in financing to scale its at-home …
-
Virax Biolabs enters immune profiling product supply deal with Fosun
Virax Biolabs Group subsidiary Virax Biolabs (UK) has signed an exclusive commercial supply agreement with Fosun Diagnostics for its research-use-only …
-
Otsuka ICU Medical outlays $500m to expand US manufacturing footprint
Otsuka ICU Medical is investing $500m into expanding its US-based IV manufacturing provision to improve long-term supply resiliency. The company, established …
